| HOME >> BIOLOGY >> TECHNOLOGY |
WALTHAM, Mass., April 24 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a global leader in rapid point-of-care diagnostic products, today announced its financial results for the quarter ended March 31, 2008.
In the first quarter of 2008, the Company recorded net revenue of
$372.2 million compared to net revenue of $159.0 million in the first
quarter of 2007. The revenue increase was primarily due to increased
product and service revenue in our Professional Diagnostics segment which
grew from $83.8 million in the first quarter of 2007 to $259.6 million in
2008, principally as a result of businesses acquired which contributed
$152.4 million of the increased product and service revenue. Also
contributing to the net revenue increase was product and service revenue
provided by our newly formed Health Management segment totaling $45.2
million in the first quarter of 2008. In addition, total royalty and
license revenue grew from $5.2 million in the first quarter of 2007 to
$10.9 million in 2008, principally as a result of businesses acquired which
contributed $4.4 million of the increased royalty and license revenue. As a
result of the formation of our Consumer Diagnostics joint venture with The
Procter & Gamble Company, we no longer consolidate the third party revenues
earned on sales of consumer products sold through the joint venture and
instead recognized product sales to the joint venture of $28.9 million in
the first quarter of 2008 compared to pre-joint venture formation revenues
of $49.9 million in the first quarter of 2007. Despite the $21.0 million of
decreased revenues included in our consolidated results, underlying
Consumer Diagnostics revenues recorded by the joint venture increased to
$54.7 millio
'/>"/>
| SOURCE Inverness Medical Innovations, Inc. Copyright©2008 PR Newswire. All rights reserved |